Systematic screening highlights LyondellBasell Industries NV as a chemicals sector contrarian case, with the stock trading at $62.08 within a $41.58-$83.94 52-week range while navigating significant profitability headwinds. The company's market capitalization stands at $20.0 billion, yet the model indicates notable stress metrics: negative ROE of -7.41%, negative EPS of $-2.45, and revenue contraction of -22.02% year-over-year. The absence of a trailing P/E ratio reflects recent earnings challenges that distinguish LYB from typical large-cap chemical producers.

The fundamental screener identifies several structural strengths despite cyclical pressures. The current ratio of 1.77 indicates adequate liquidity positioning for near-term obligations, while the debt-to-equity ratio of 1.28 remains within manageable parameters for capital-intensive chemical manufacturing. The price-to-sales ratio of 0.66 and price-to-book ratio of 1.38 position LYB at significant discounts to historical chemical sector averages, reflecting market pricing of operational difficulties. Additionally, the beta of 0.36 signals considerably lower volatility than broader market indices, which research perspectives associate with defensive characteristics during uncertain economic periods.

Risk factors warrant attention: operating margin of -1.01% and net margin of -2.66% reveal profitability erosion across the operational structure, while gross margin compression to 9.2% suggests pricing power deterioration or input cost pressures. The book value per share of $31.3 substantially exceeds the current share price, indicating potential asset value recognition gaps.

Relative to peers ESNT.L and ZTF.L, LYB's valuation discount combined with a markedly lower beta creates a distinct profile for systematic screens prioritizing stability metrics over momentum characteristics in the global chemicals landscape.